Latest News in the pharma Industry

Biopharma News

Allergan to establish R&D presence in Cambridge, Massachusetts

Allergan to establish R&D presence in Cambridge, Massachusetts

10 Jan 2019

The new, strategic presence will allow the company to more easily interact and engage with venture firms and start ups in the area.

Read more 
Expedeon signs supply and license agreement for is Lightning-Link technology

Expedeon signs supply and license agreement for is Lightning-Link technology

9 Jan 2019

The technology will enable Cell Guidance Systems to manufacture TRIFic detection assays on-demand with highly reproducible and scalable results.

Read more 
Catalent to double its commercial biomanufacturing capacity

Catalent to double its commercial biomanufacturing capacity

7 Jan 2019

The $200-million expansion will support customers’ development programs and commercial launches.

Read more 
BMS and Celgene merge to create premier innovative biopharma company

BMS and Celgene merge to create premier innovative biopharma company

3 Jan 2019

Significantly expands Phase III assets with six expected near-term product launches, representing greater than $15 billion in revenue potential.

Read more 
Pall opens Center of Excellence in Shanghai

Pall opens Center of Excellence in Shanghai

19 Dec 2018

The CoE showcases the latest end-to-end technological solutions for biomanufacturing.

Read more 
New gene therapy manufacturing facility for Orchard Therapeutics

New gene therapy manufacturing facility for Orchard Therapeutics

13 Dec 2018

Enhances company's capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells for wide range of diseases on a global scale.

Read more 
Grant winners to investigate continuous manufacturing for gene therapies

Grant winners to investigate continuous manufacturing for gene therapies

26 Nov 2018

Cobra Biologics, Pall, and the Cell and Gene Therapy Catapult share £1.5 million grant from the UK's innovation agency.

Read more 
ADC Bio secures additional equity round investment

ADC Bio secures additional equity round investment

19 Nov 2018

Extra funding for strategic move into downstream formulation and fill finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm.

Read more 
SSB and Lonza modify relationship for supply of cell culture media

SSB and Lonza modify relationship for supply of cell culture media

18 Nov 2018

Sartorius Stedim Biotech will continue to offer Lonza media and buffer products but under a non-exclusive agreement.

Read more 
bioLIVE to merge with BioProduction Congress for 2019 event

bioLIVE to merge with BioProduction Congress for 2019 event

7 Nov 2018

BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the bio industry.

Read more 
Sandoz pulls the plug on US biosimilar rituximab

Sandoz pulls the plug on US biosimilar rituximab

4 Nov 2018

Company will focus on robust biosimilar portfolio for unmet access and sustainability needs.

Read more 
Three-way collaboration to advance gene therapy

Three-way collaboration to advance gene therapy

4 Oct 2018

Partnership aims to increase the robustness and reduce costs for the manufacturing of AAV vectors.

Read more